James Vincent Lambert

GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD.

Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.

Stone Street Capital, Inc. provides lottery and structured settlement lump sum services. The company was founded by Lee Jundanian in 1989 and is headquartered in Bethesda, MD.

Oncormed, Inc., is a genomics services company that characterizes newly discovered genes to establish their medical relevance and provides molecular profiling of patients for pharmacogenomic and therapeutic purposes. The company's mission is to accelerate the translation of cancer related genetic discoveries into clinically useful products and services through strategic collaborations with pharmaceutical, genomic and biotechnology companies.

Part of Precigen, Inc., PGEN Therapeutics, Inc. develops gene and cellular therapies. The company is based in Henrico, MD.